Li KHC, Lee S, Yin C, Liu T, Ngarmukos T, Conte G, Yan GX, Sy RW, Letsas KP, Tse G (2020) Brugada syndrome: a comprehensive review of pathophysiological mechanisms and risk stratification strategies. Int J Cardiol Heart Vasc 21(26):100468. https://doi.org/10.1016/j.ijcha.2020.100468

Article  Google Scholar 

Miles C, Boukens BJ, Scrocco C, Wilde AAM, Nademanee K, Haissaguerre M, Coronel R, Behr ER (2023) Subepicardial cardiomyopathy: a disease underlying J-wave syndromes and idiopathic ventricular fibrillation. Circulation 147(21):1622–1633. https://doi.org/10.1161/CIRCULATIONAHA.122.061924

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zumhagen S, Spieker T, Rolinck J, Baba HA, Breithardt G, Böcker W, Eckardt L, Paul M, Wichter T, Schulze-Bahr E (2009) Absence of pathognomonic or inflammatory patterns in cardiac biopsies from patients with Brugada syndrome. Circ Arrhythm Electrophysiol 2(1):16–23. https://doi.org/10.1161/CIRCEP.107.737882

Article  PubMed  Google Scholar 

Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, Reichlin T, Schulz-Menger J, Sticherling C, Tzeis S, Verstrael A, Volterrani M; ESC Scientific Document Group (2022) ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 43(40):3997–4126. https://doi.org/10.1093/eurheartj/ehac262.

Russo V, Pafundi PC, Caturano A, Dendramis G, Ghidini AO, Santobuono VE, Sciarra L, Notarstefano P, Rucco MA, Attena E, Floris R, Romeo E, Sarubbi B, Nigro G, D’Onofrio A, Calò L, Nesti M (2021) Electrophysiological study prognostic value and long-term outcome in drug-induced type 1 Brugada syndrome: the IBRYD study. JACC Clin Electrophysiol 7(10):1264–1273. https://doi.org/10.1016/j.jacep.2021.03.010

Article  PubMed  Google Scholar 

Russo V, Caturano A, Guerra F, Migliore F, Mascia G, Rossi A, Nesti M, Santobuono VE, Attena E, Tola G, Sciarra L, Conte G, Paoletti Perini A, Francia P, Dendramis G, Palamà Z, Albani S, Ottonelli Ghidini A, Calò L, D'Onofrio A, Baldi E; IBRYD Study Group (2023) Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study. Heart Vessels 38(5):680–688. https://doi.org/10.1007/s00380-022-02204-x

Kawada S, Morita H, Antzelevitch C, Morimoto Y, Nakagawa K, Watanabe A, Nishii N, Nakamura K, Ito H (2018) Shanghai score system for diagnosis of Brugada syndrome: validation of the score system and system and reclassification of the patients. JACC Clin Electrophysiol 4(6):724–730. https://doi.org/10.1016/j.jacep.2018.02.009

Article  PubMed  Google Scholar 

Delise P (2021) Risk stratification in Brugada syndrome: the challenge of the grey zone. Eur Heart J 42(17):1696–1697. https://doi.org/10.1093/eurheartj/ehaa1100

Article  PubMed  Google Scholar 

Wilde AAM, Amin AS, Morita H, Tadros R (2023) Use, misuse, and pitfalls of the drug challenge test in the diagnosis of the Brugada syndrome. Eur Heart J 44(27):2427–2439. https://doi.org/10.1093/eurheartj/ehad295

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aziz HM, Zarzecki MP, Garcia-Zamora S, Kim MS, Bijak P, Tse G, Won HH, Matusik PT (2022) Pathogenesis and management of Brugada syndrome: recent advances and protocol for umbrella reviews of meta-analyses in major arrhythmic events risk stratification. J Clin Med 11(7):1912. https://doi.org/10.3390/jcm11071912

Article  CAS  PubMed  PubMed Central  Google Scholar 

Probst V, Goronflot T, Anys S, Tixier R, Briand J, Berthome P, Geoffroy O, Clementy N, Mansourati J, Jesel L, Dupuis JM, Bru P, Kyndt F, Wargny M, Guyomarch B, Thollet A, Mabo P, Gourraud PA, Behar N, Sacher F, Gourraud JB (2021) Robustness and relevance of predictive score in sudden cardiac death for patients with Brugada syndrome. Eur Heart J 42(17):1687–1695. https://doi.org/10.1093/eurheartj/ehaa763

Article  PubMed  Google Scholar 

Probst V, Veltmann C, Eckardt L, Meregalli PG, Gaita F, Tan HL, Babuty D, Sacher F, Giustetto C, Schulze-Bahr E, Borggrefe M, Haissaguerre M, Mabo P, Le Marec H, Wolpert C, Wilde AA (2010) Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada syndrome registry. Circulation 121(5):635–643. https://doi.org/10.1161/CIRCULATIONAHA.109.887026

Article  CAS  PubMed  Google Scholar 

Eckardt L, Probst V, Smits JP, Bahr ES, Wolpert C, Schimpf R, Wichter T, Boisseau P, Heinecke A, Breithardt G, Borggrefe M, LeMarec H, Böcker D, Wilde AA (2005) Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 111(3):257–263. https://doi.org/10.1161/01.CIR.0000153267.21278.8D

Article  PubMed  Google Scholar 

Chen C, Tan Z, Zhu W, Fu L, Kong Q, Xiong Q, Yu J, Hong K (2020) Brugada syndrome with SCN5A mutations exhibits more pronounced electrophysiological defects and more severe prognosis: a meta-analysis. Clin Genet 97(1):198–208. https://doi.org/10.1111/cge.13552

Article  CAS  PubMed  Google Scholar 

Doundoulakis I, Pannone L, Chiotis S, Della Rocca DG, Sorgente A, Tsioufis P, Del Monte A, Vetta G, Piperis C, Overeinder I, Bala G, Almorad A, Ströker E, Sieira J, La Meir M, Brugada P, Tsiachris D, Sarkozy A, Chierchia GB, de Asmundis C (2024) SCN5A gene variants and arrhythmic risk in Brugada syndrome: an updated systematic review and meta-analysis. Heart Rhythm S1547–5271(24):02374–02379. https://doi.org/10.1016/j.hrthm.2024.04.047

Article  Google Scholar 

Meregalli PG, Tan HL, Probst V, Koopmann TT, Tanck MW, Bhuiyan ZA, Sacher F, Kyndt F, Schott JJ, Albuisson J, Mabo P, Bezzina CR, Le Marec H, Wilde AA (2009) Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Heart Rhythm 6(3):341–348. https://doi.org/10.1016/j.hrthm.2008.11.009

Article  PubMed  Google Scholar 

Ishikawa T, Kimoto H, Mishima H, Yamagata K, Ogata S, Aizawa Y, Hayashi K, Morita H, Nakajima T, Nakano Y, Nagase S, Murakoshi N, Kowase S, Ohkubo K, Aiba T, Morimoto S, Ohno S, Kamakura S, Nogami A, Takagi M, Karakachoff M, Dina C, Schott JJ, Yoshiura KI, Horie M, Shimizu W, Nishimura K, Kusano K, Makita N (2021) Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome. Eur Heart J 42(29):2854–2863. https://doi.org/10.1093/eurheartj/ehab254

Article  CAS  PubMed  Google Scholar 

Yamagata K, Horie M, Aiba T, Ogawa S, Aizawa Y, Ohe T, Yamagishi M, Makita N, Sakurada H, Tanaka T, Shimizu A, Hagiwara N, Kishi R, Nakano Y, Takagi M, Makiyama T, Ohno S, Fukuda K, Watanabe H, Morita H, Hayashi K, Kusano K, Kamakura S, Yasuda S, Ogawa H, Miyamoto Y, Kapplinger JD, Ackerman MJ, Shimizu W (2017) Genotype-phenotype correlation of SCN5A mutation for the clinical and electrocardiographic characteristics of probands with Brugada syndrome: a Japanese multicenter registry. Circulation 135(23):2255–2270. https://doi.org/10.1161/CIRCULATIONAHA.117.027983

Article  CAS  PubMed  Google Scholar 

Russo V, Caturano A, Migliore F, Guerra F, Francia P, Nesti M, Conte G, Perini AP, Mascia G, Albani S, Marchese P, Santobuono VE, Dendramis G, Rossi A, Attena E, Ghidini AO, Sciarra L, Palamà Z, Baldi E, Romeo E, D'Onofrio A, Nigro G; IBRYD Study Group (2024) Long-term clinical outcomes of patients with drug-induced type 1 Brugada electrocardiographic pattern: a nationwide cohort registry study. Heart Rhythm 21(5):555–561. https://doi.org/10.1016/j.hrthm.2024.01.015

Gaita F, Cerrato N, Giustetto C, Martino A, Bergamasco L, Millesimo M, Barbonaglia L, Carvalho P, Caponi D, Saglietto A, Bonacchi G, Bianchi F, Silvetti E, Crescenzi C, Canestrelli S, De Maio M, De Ferrari GM, Musumeci G, Rametta F, Scaglione M, Calò L (2023) Asymptomatic patients with Brugada ECG pattern: long-term prognosis from a large prospective study. Circulation 148(20):1543–1555. https://doi.org/10.1161/CIRCULATIONAHA.123.064689

Article  CAS  PubMed  PubMed Central  Google Scholar 

Viskin S, Chorin E, Rosso R, Amin AS, Wilde AA (2024) Diagnosis of Brugada syndrome with a sodium-channel-blocker test: who should be tested? Who should not? Circulation 150(8):642–650. https://doi.org/10.1161/CIRCULATIONAHA.124.069138

Article  CAS  PubMed  Google Scholar